Methods | Randomised, parallel‐group trial conducted in a rural district of West Bengal, India 2 treatment arms: PHB and PHT |
|
Participants | Children from a rural district of a developing country (India) who had experienced 2 or more unprovoked seizures within the 12 months preceding the trial and had been untreated in the 3 months preceding the trial Number randomised: PHB = 47 ; PHT = 47 47 boys (50%) 60 children had partial epilepsy (64%) Mean age (range): 11 (2‐18) years |
|
Interventions | Monotherapy with PHB or PHT Maintenance doses: PHT = 5 mg/kg/d, PHB = 3 mg/kg/d. Daily dose achieved not stated Range of follow‐up: 0.5‐13 months |
|
Outcomes | Time to first seizure Proportion seizure‐free in each trial quarter Proportion of adverse events including behavioural side effects |
|
Notes | IPD provided for remission and seizure outcomes of this review by the trial author. Withdrawal information not available | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | First 10 participants randomised from a pre‐prepared balanced random number list, following participants randomised by minimisation with stratification by age group and presence of cerebral impairment |
Allocation concealment (selection bias) | Unclear risk | No information provided |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Participants, parents and treating physicians unblinded for “practical and ethical reasons.” Withdrawal information from treatments not available, however lack of blinding may have influenced withdrawal rates |
Blinding of outcome assessment (detection bias) All outcomes | Low risk | Outcome assessors single‐blinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Attrition rates reported, ITT approach, all randomised participants analysed from IPD provided (see footnote 2) |
Selective reporting (reporting bias) | Low risk | All outcomes reported or calculated with IPD provided (see footnote 2) |
Other bias | Low risk | None identified |